• 1
    Parker SL, Tong T, Bolden S, Wingo PA. Cancer statistics, 1996. CA Cancer J Clin 1996; 46: 527.
  • 2
    Mandel JS, Bond JH, Church TR, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. N Engl J Med 1993; 328: 136571.
  • 3
    Kronborg O, Fenger C, Olsen J, Jorgensen OD, Sondergaard O. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet 1996; 348: 146771.
  • 4
    Hardcastle JD, Chamberlain JO, Robinson MHE, et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 1996; 348: 147277.
  • 5
    Selby JV, Friedman GD, Quesenberry CP, Weiss NS. A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med 1992; 326: 65357.
  • 6
    Newcomb PA, Norfleet RG, Storer BE, Surawicz TS, Marcus PM. Screening sigmoidoscopy and colorectal cancer mortality. J Natl Cancer Inst 1992; 84: 157275.
  • 7
    Wagner JL, Tunis S, Brown M, Ching A, Almeida R. Cost-effectiveness of colorectal cancer screening in average-risk adults. In: Young, GP, Rozen, P, Levin, B, eds. Prevention and Early Detection of Colorectal Cancer, 1st edn. Philadelphia: WB Saunders, 1996.
  • 8
    Lieberman D. Cost-effectiveness model for colon cancer screening. Gastroenterology 1995; 109: 178190.
  • 9
    Frazier AL, Colditz GA, Fuchs CS, Kuntz KM. Cost-effectiveness of screening for colorectal cancer in the general population. JAMA 2000; 284: 195461.
  • 10
    Sonnenberg A, Delco F, Inadomi JM. Cost-effectiveness of colonoscopy in screening for colorectal cancer. Ann Intern Med 2000; 133: 57384.
  • 11
    Eddy DM. Screening for colorectal cancer. Ann Intern Med 1990; 113: 37384.
  • 12
    Khandker RK, Dulski JD, Kilpatrick JB, Ellis RP, Mitchell JB. A decision model and cost-effectiveness analysis of colorectal cancer screening and surveillance guidelines for average-risk adults. Int J Technol Assess Health Care 2000; 16: 799810.
  • 13
    Loeve F, Brown ML, Boer R, van Ballegooijen M, van Oortmarssen GJ, Habbema DF. Endoscopic colorectal cancer screening: a cost-saving analysis. J Natl Cancer Inst 2000; 92: 55763.
  • 14
    Vijan S, Hwang EW, Hofer TP, Hayward RA. Which colon cancer screening test? A comparison of costs, effectiveness, and compliance. Am J Med 2001; 111: 593601.
  • 15
    Levin B, Bond JH. Colorectal cancer screening: recommendations of the US Preventive Services Task Force. American Gastroenterological Association. Gastroenterology 1996; 111: 13814.
  • 16
    Winawer SJ, Fletcher RH, Miller L, et al. Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology 1997; 112: 594642.
  • 17
    Byers T, Levin B, Rothenberger D, Dodd GD, Smith RA. American Cancer Society guidelines for screening and surveillance for early detection of colorectal polyps and cancer: update 1997. CA Cancer J Clin 1997; 47: 15460.
  • 18
    Zucker J. Katie Couric's Inside Story. The Washington Post, 6 March 2000; C: 7.
  • 19
    Cram P, Inadomi J, Cowen ME, Carpenter D, Fendrick AM, Vijan S. The impact of a healthy celebrity spokesperson on preventive health behavior: The Katie Couric Effect. Arch Int Med 2003; 163: 16015.
  • 20
    Anderson LM, May DS. Has the use of cervical, breast, and colorectal cancer screening increased in the United States? Am J Public Health 1995; 85: 8402.
  • 21
    Brown ML, Potosky AL, Thompson GB, Kessler LG. The knowledge and use of screening tests for colorectal and prostate cancer: data from the 1987 National Health Interview Survey. Prev Med 1990; 19: 56274.
  • 22
    Kolata G. 50 and Ready for Colonoscopy? Doctors Say Wait Is Often Long. New York Times A ed. December 8, New York, NY: New York Times, 2003: 1.
  • 23
    US Census Bureau. US Summary: 2000. Census 2000 Profile. 2002; Washington, DC: US Department of Commerce. Economics and Statistics Administration.
  • 24
    US Department of Health and Human Services. Healthy People 2010. Accessed Jan 12, 2004. Available at:
  • 25
    Ahluwalia IB, Mack KA, Murphy W, Mokdad AH, Bales VS. State-specific prevalence of selected chronic disease-related characteristics – behavioral Risk Factor Surveillance System, 2001. MMWR CDC Surveill Summ 2003; 52: 180.
  • 26
    Juster FT, Suzman R. An overview of the health and retirement study. J Hum Resour 1995; 30(Suppl.): S7S56.
  • 27
    Lieberman DA, DeGarmo PL, Fleischer DE, Eisen GM, Helfand M. Patterns of endoscopy use in the United States. Gastroenterology 2000; 119: 61924.
  • 28
    American Board of Internal Medicine. Examination data page, 2002. Accessed Nov 15, 2003. Available at:
  • 29
    Brown ML, Klabunde CN, Mysliwiec P. Current capacity for endoscopic colorectal cancer screening in the United States: data from the National Cancer Institute survey of colorectal cancer screening practices. Am J Med 2003; 115: 12933.
  • 30
    Anonymous. Trends in screening for colorectal cancer – United States, 1997 and 1999. MMWR Morb Mortal Wkly Rep 2001; 50: 1626.
  • 31
    Pathmakanthan S, Murray I, Smith K, Heeley R, Donnelly M. Nurse endoscopists in United Kingdom health care: a survey of prevalence, skills and attitudes. J Adv Nursing 2001; 36: 70510.
  • 32
    Schoenfeld P, Piorkowski M, Allaire J, Ernst R, Holmes L. Flexible sigmoidoscopy by nurses: state of the art 1999. Gastroenterol Nurs 1999; 22: 25461.